RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,728,000 | -23.5% | 800,000 | +14.3% | 0.93% | -14.5% |
| Q2 2023 | $8,792,000 | -30.7% | 700,000 | -9.1% | 1.09% | -57.4% |
| Q1 2023 | $12,681,900 | +35.8% | 770,000 | +23.2% | 2.56% | +30.4% |
| Q4 2022 | $9,337,500 | -30.4% | 625,000 | +4.2% | 1.96% | -24.8% |
| Q3 2022 | $13,422,000 | +83.7% | 600,000 | +37.5% | 2.61% | +73.5% |
| Q2 2022 | $7,307,000 | -25.3% | 436,262 | +33.4% | 1.50% | -41.0% |
| Q1 2022 | $9,787,000 | +41.6% | 327,000 | +45.3% | 2.55% | +33.2% |
| Q4 2021 | $6,910,000 | +56.5% | 225,000 | +60.7% | 1.91% | +50.7% |
| Q3 2021 | $4,414,000 | +0.5% | 140,000 | +16.7% | 1.27% | +5.0% |
| Q2 2021 | $4,391,000 | +111.7% | 120,000 | +100.0% | 1.21% | +103.9% |
| Q1 2021 | $2,074,000 | – | 60,000 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |